It had been recommended in 2020 by the Centers for Disease Control (CDC) that serodiagnosis of acute rickettsiosis specifically utilize the IFA-IgG assay. This was a new and curious requirement for all testing facilities, namely the use of an assay that was neither described in detail nor actually relevant for acute phase diagnosis of a potentially fatal disease. A detailed protocol for this assay should have been included in this announcement to encourage rapid compliance, along with a detailed explanation of the relevance of this specific assay. This was not the case, however, with the result being false-negative IFA-IgG reports over several seasons nationally.
Keywords:
Published on: Oct 2, 2026 Pages: 4-5
Full Text PDF
Full Text HTML
DOI: 10.17352/apm.000041
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat